China Produces World's First Gene-Edited Dogs Using CRISPR/Cas9 System

被引：0
|
作者：
机构：
来源：
Bulletin of the Chinese Academy of Sciences | 2015年 / 04期
关键词：
World; time; Gene; China Produces World’s First Gene-Edited Dogs Using CRISPR/Cas9 System; gene;
D O I：
暂无
中图分类号：
Q789 [基因工程的应用];
学科分类号：
071007 ; 0836 ; 090102 ;
摘要：
Dogs exhibit close similarities to humans in terms of metabolic,physiological,and anatomical characteristics,and thus are ideal genetic and clinical models to study human diseases.Gene target technology is a powerful tool to create new strains of animals with favorable trails.However,gene-target dogs were not developed for a long time due to their unique species-specific reproductive characteristics which limited their applications,especially in the field of biomedical research.Recently.LAI Liangxue and his coworkers from
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [31] High Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells
    Carlson-Stevermer, Jared
    Goedland, Madelyn
    Steyer, Benjamin
    Movaghar, Arezoo
    Lou, Meng
    Kohlenberg, Lucille
    Prestil, Ryan
    Saha, Krishanu
    MOLECULAR THERAPY, 2016, 24 : S229 - S230
  • [32] Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Hasan Mollanoori
    Shahram Teimourian
    Biotechnology Letters, 2018, 40 : 907 - 914
  • [33] Fanconi Anemia Gene Editing by the CRISPR/Cas9 System
    Osborn, Mark J.
    Gabriel, Richard
    Webber, Beau R.
    DeFeo, Anthony P.
    McElroy, Amber N.
    Jarjour, Jordan
    Starker, Colby G.
    Wagner, John E.
    Joung, J. Keith
    Voytas, Daniel F.
    von Kalle, Christof
    Schmidt, Manfred
    Blazar, Bruce R.
    Tolar, Jakub
    HUMAN GENE THERAPY, 2015, 26 (02) : 114 - 126
  • [34] Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Mollanoori, Hasan
    Teimourian, Shahram
    BIOTECHNOLOGY LETTERS, 2018, 40 (06) : 907 - 914
  • [35] Recreation of Fetal Neonatal Alloimmune Thrombocytopenia in CRISPR/Cas9 Gene-Edited Mice Expressing the Human Platelet Alloantigen, HPA-1a
    Zhi, Huiying
    Ahlen, Maria Therese
    Skogen, Bjorn
    Newman, Peter
    BLOOD, 2017, 130
  • [36] Guidelines for optimized gene knockout using CRISPR/Cas9
    Van Campenhout, Claude
    Cabochette, Pauline
    Veillard, Anne-Clemence
    Laczik, Miklos
    Zelisko-Schmidt, Agnieszka
    Sabatel, Celine
    Dhainaut, Maxime
    Vanhollebeke, Benoit
    Gueydan, Cyril
    Kruys, Veronique
    BIOTECHNIQUES, 2019, 66 (06) : 295 - 302
  • [37] The enhancement of CRISPR/Cas9 gene editing using metformin
    Rollins, Jaedyn L.
    Hall, Raquel M.
    Lemus, Clara J.
    Leisten, Lauren A.
    Johnston, Jennifer M.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [38] Gene editing using CRISPR/Cas9 in neuromuscular disorders
    Gonorazky, H.
    Maani, N.
    Khattak, S.
    Ivakine, Z.
    Cohn, R.
    Dowling, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S127 - S127
  • [39] CRISPR/Cas9 Edited Hematopoietic Stem and Progenitor Cells for Friedreich's Ataxia
    Sivakumar, Anusha
    Badell-Grau, Rafael Andres
    Wan, Rita
    Khare, Veenita
    Cherqui, Stephanie
    MOLECULAR THERAPY, 2023, 31 (04) : 639 - 639
  • [40] CASGEVY Makes History as FDA Approves First CRISPR/Cas9 Genome Edited Therapy
    Philippidis, Alex
    HUMAN GENE THERAPY, 2024, 35 (1-2) : 1 - 4
12345